Ledger.Open graph →
SEC Form D · filed November 20, 2014

Blueprint Medicines Corp

Offering
$50.0M
Sold
$50.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Christine W. Bellon · Cambridge, MAExecStephen S. Knight · Cambridge, MADirectorKyle W. Kuvalanka · Cambridge, MAExecThilo S. Schroeder · Cambridge, MADirectorAlexis S. Borisy · Cambridge, MADirectorChristoph S. Lengauer · Cambridge, MAExecDavid S. Schenkein · Cambridge, MADirectorDaniel S. Lynch · Cambridge, MADirectorNicholas S. Lydon · Cambridge, MADirectorJeffrey W. Albers · Cambridge, MAExec · DirectorJesse Brunner · Santa Monica, CADirectorSteve Adler · Santa Monica, CADirectorMaurice Singer · Santa Monica, CADirectorHarshvardhan P. Sharangpani · Los Altos Hills, CADirectorAlan N. Solon · Atlanta, GAExecRobert M. Mccullough · Atlanta, GAExecClive R. Slovin · Atlanta, GAExecDavid S. Schenkein · Cambridge, MADirectorNicholas S. Lydon · Cambridge, MADirectorJeffrey W. Albers · Cambridge, MAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗